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0.0 Abstract
Autophagy is the process by which cytosolic components are trafficked to and degraded
by the vacuole or lysosome. It plays a critical role in cellular health, aging, cancer, and
neurodegenerative diseases. Atg7 and Atgl4 are enzymes required for the autophagic process in

Saccharomyces cerevisiae. In this study, we hypothesized that Atg7 controls the size while
Atg 14 controls the number of autophagosomes. Using western blotting, Pho8D.60 assay and
transmission electron microscopy analysis, we found that Atg7 affects both the size and number
of autophagosomes. In addition, we have created cells expressing various levels of Atgl4 using
non-native promoters. In addition, we applied the significance of these results to better
understand the therapeutic application of mammalian autophagy.
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1.0 Introduction
Autophagy, which translates to 'self eating,' is a crucial cellular process in which
intracellular components are degraded in order to relieve the cell from various stress conditions 1•
Macroautophagy (hereafter referred to as autophagy) is a eukaryotic process where unwanted
cellular components are sequestered into a double membrane vesicle referred to as an
autophagosome. The autophagosome then fuses to the vacuole (in yeast) or the lysosome (in
mammals), where the components are degraded by lysosomal acid proteases. The broken down
materials (such as amino acids and other small molecules) that are generated by this degradation
are delivered back to the cytoplasm for recycling or as energy resources2 (Figure 1).
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Figure 1: Schematic diagram ofautophagy. The process begins the fonnation ofan isolation membrane
around the cargo. The membrane expands into an autophagosome and fuses with the vacuole/lysosome
for degradation. Figure from Reference 15.
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There are two main types of autophagy: selective and non-selective. In selective
autophagy, particular components are targeted into the autophagosome for degradation by
selective autophagy receptors. These components include damaged organelles (such as
mitochondria, endoplasmic reticulum, and peroxisomes), protein aggregates, and intracellular
pathogens. However, upon nutrient starvation, cytosolic components are non-selectively
sequestered into autophagosomes for degradation, which is known as non-selective autophagy.3
Both types of autophagy play an equally important role in maintaining cellular
homeostasis and function. Non-selective autophagy allows for the cell to survive during
starvation conditions, whereas selective autophagy allows the cell to remove specific unwanted
constituents and prolong cellular senescence. These functions give autophagy a key role in
preventing diseases such as cancer, neurodegeneration, diabetes, cardiomyopathy, autoimmune
diseases, and infections.4 For example, autophagy is considered to be a tumor-suppressing
mechanism during tumor initiation and malignant transformation. The degradation of damaged
organelles limits the proliferation of cancerous cells and genomic instability.5 Also,
neurodegenerative diseases, such as Alzheimer's and Parkinson's disease, are due to the
aggregation of protein leading to neuronal plaques. This accumulation of aggregated protein can
be cleared through autophagic degradation.6 These studies show the effects on various diseases
due to a change in a specific mammalian autophagy gene. However, these studies do not outline
the intermediate steps that explain how these genetic changes affect autophagy and thus lead to
the disease. Instead,autophagy is more easily studied in model organisms (such as yeast) to be
able to determine the molecular steps. This suggests that research on the molecular role of
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autophagy proteins in yeast will allow us to better understand the results of mammalian
autophagy in disease.
Autophagy requires a variety of autophagy-related (Atg) proteins to occur. Genetic
models have been developed in baker's yeast (Saccharomyces cerevisiae), which makes it easy
to study the molecular role of these proteins. There arc approximately 30 Atg proteins that have
been identified in yeast, many of which have homologs in humans.7 There are 18 Atg proteins
which are essential for autophagy,8 and some of them are upregulated during periods of
starvation.9 This suggests that the amount of that protein dictates the amount of autophagy
occurring by affecting autophagosome size and/or number. Increasing the size of the
autophagosomc would increase the volume uptake and would increase autophagic flux since
there is more to be degraded. Increasing the number of autophagosomes would also allow for
more uptake of cytosolic components and likewise lead to an increase in autophagic flux.
The Klionsky lab tested this idea by looking at the function of an autophagic protein
called Atg8. They chose Atg8 since it is one of the core machinery proteins that is upregulated
during autophagy and plays a big role in autophagosome formation (Figure 2). First, they created
mutant yeast strains with various nonnative promoters in front of the ATG8 gene to control
protein levels. Then, they performed a western blot to verify expression levels, a Pho8�60 assay
to measure the autophagic flux and transmission electron microscopy (TEM) to compare the
average size and number of autophagosomes per cell. Using this method, they showed that a
decrease in Atg8 protein levels leads to reduced autophagic flux due to a decrease in
autophagosome size. 10 In contrast, it was shown by the same method in another study that a
decrease in Atg9 levels lead to a decrease in autophagosome number, and not size. 11 This
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methodology is very significant as it is currently the only way to detennine whether a protein
affects autophagosome size vs autophagosome number. The protein's effect on autophagosome
size and number can give insight the step of autophagy that the protein is involved in. Therefore,
our lab wanted to utilize this novel methodology to help define the roles of other proteins
involved in autophagy.
One of the proteins that our lab focused on was Atg7. Atg7 is one of the essential
autophagic proteins which is strongly regulated upon nutrient starvation. It is an El-like
activating enzyme required for autophagosome formation and is involved in the Atgl2-5
conjugation and Atg8-PE conjugation system. Atg8 requires an El activating enzyme(Atg7), an
E2 enzyme (Atg3) and an E3 complex (Atg12-5) to conjugate to phosphoethanolamine (PE).
Atg12 also requires an El activating enzyme (Atg7) and an E2 enzyme (Atgl0) to conjugate
Atg5 (Figure 2). Our group also investigated Atg14, which is a protein involved in the
phosphatidylinositol 3-kinase (PBK) complex. The PI3K complex phosphorylates PI into PI3P,
which is a necessary step in autophagosome formation. It also interacts with itself to promote the
fusion of autophagosomes with the vacuolc/lysosome. 12
Both Atg7 and Atg14's role in affecting autophagosome size and/or number has not been
identified. Our lab used the methodology described above to determine this role. We proposed
that Atg7 would affect the size of autophagosomes since Atg7 is upstream of Atg8 and Atg8
controls the size of autophagosomes. 13 Since Atg14 is responsible for the formation of the
autophagosome and is involved upstream in the membrane fusion process. 14 Understanding the
molecular roles of these proteins will allow us to better understand the autophagic process,
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overall. Understanding this process on a molecular level is a critical step towards the creation of
medication which can regulate levels of autophagy, with many potential health benefits.

Atg8 System

Pl3K-III Complex

El

"
Figure 2: The core autophagic machinery. Atg7 is a part of the Atg8-PE and Atgl2-5 conjugation

system. The conjugation of Atg8 to PE involves an El activating enzyme (Atg7), an E2 enzyme (Atg3)
and an E3 complex (Atgl2-5). Atgl4 is part of the PI3K-III complex and phosphorylates Pl to PI3P,
which is a necessary step for autophagosome formation. Figure created by Ronith Chakraborty in Adobe
Illustrator CC 2017.
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2.0 Methodology
2.1 Plasmid Construction
The plasmids used in this study are listed in Table 1, and the primers used are listed in
Table 2. Atg7-expressing pRS416 plasmids with distinct promoters13 were provided as a gift by
Dr. Dan Klionsky and were purified using the Quick Plasmid Miniprep kit (lnvitrogen). To
construct Atg7-expressing pRS406 plasmids, the entire pRS416 plasmid except for the CEN6
sequence was amplified by PCR using phosphorylated primers (306 and 307) annealing on either
side of the CEN6 sequence. PCR was performed using Phusion Polymerase (NEB) and cleaned
up using the NucleoSpin DNA and PCR Clean-up Kit (Macherey-Nagel). The plasmids were
ligated by T4 DNA ligasc (NEB) and then they were checked for the absence of CEN6 sequence
by PCR using flanking primers (315 and 316).
Atgl4-expressing plasmids were created by PA-tagging Atgl 4 using Longtine-Pringle
primers 384 and 385 and a pFA6-PA vector as the template. 16 This tag was then transformed into
WLY176 strain and the expression of ATG14-PA was verified via western blot with PAP
antibodies and the resulting autophagic activity was verified by Pho8660. Atgl4-PA including
1000 hp of 5' genomic sequence was amplified out ofWLYl 76 genomic DNA by PCR using
primers 309 and 404. To construct pRS406-ATG14-PA plasmids, ATG14-PA was inserted into
pRS406 (linearized by EcoRJ and HindIII} using Infusion cloning (In-Fusion® HD EcoDryTM
Cloning Kit - Takara Bio). The ATG14 promoter was then removed from the resulting plasmid,
pRS406-ATGJ4p-ATG14-PA, using primers 313 and 418. Then, potential promoters were

selected (based on published RNA Sequence data17) to give a wide range of Atgl4 levels. Those
promoters were ATG1p, ATG8p, GAL3p, and ATG23p and they were amplified from genomic
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yeast DNA using primer pairs (308/416, 324/417, 355/415, and 328/414, respectively) and
inserted by Infusion cloning to create the resulting plasmids(l 1-16).

2.2 Strain Construction
The strains used in this study are listed in Table 3. Yeast transformation and genomic
DNA purification were performed using published methods. 18"' ATG7 was deleted from
19

FRY143 and WLYI 76 by homologous recombination with a PCR fragment containing a
histidine gene flanked by ~500 bp ofATG7 5' and 3' genome sequence. This fragment was
generated by PCR using primers (292 and 293) that flankATG7 and genomic DNA from an
atg7L1:: HIS5 strain (YAB292) as a template. The resulting strains (SK.8421 and SK.8447) were

verified by PCR to check for the presence of the HIS gene using primers 292 and 311 and the
absence of the ATG7 gene using primers 292 and 312. To integrate ATG7 under various
promoters into the ura3 locus, each pRS406 plasmid was digested with Ncol enzyme, which
made a single cut in the URA3 gene. The digests were heat killed at 85-90° C for 20 minutes and
then transformed into log phase SKB421 and SKB447 to create the desired strains.
ATG14 was deleted from WLY176 by homologous recombination with a PCR fragment

containing a kanamycin gene flanked by ~40 hp of ATGJ4 5' and 3' genome sequence. This
fragment was generated by PCR using Longtine-Pringle primers {385 and 386) that contained
sequences homologous to the 5' and 3' ends ofATG14 and pFA6-PA as a template2• The
resulting strain (SKB693) was verified by PCR to check for the presence of a larger band, due to
the KAN gene, using primers 405 and 406. To integrate ATG14 under various promoters, the
appropriate pRS406 plasmids were digested with Stul or Ncol (for GAL3p), which made a single
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cut in the URA3 gene. The digests were then transformed into log phase SKB693 to create the
desired strains (SKB738 - SKB747).

2.3 Yeast Culture
Yeast (Saccharomyces cerevisiae) were grown in YPD (1% w/v yeast extract, 2% w/v glucose,
2% w/v peptone) for normal growth conditions and SD-N (0.69 g/L YNB (yeast nitrogen base)
without amino acids and ammonium sulfate, 2% w/v glucose) for nitrogen starvation conditions.
Nitrogen starvation was induced by harvesting log phase cultures in YPD by centrifugation
(2000g for 5 minutes), washing once with sterile water and resuspending in SD-N media.
Cultures were grown (starved) for 3 hours until the time of harvest. All cultures were grown at
30°C while being shaken at 300 RPM.

2.4 Western Blotting
About 1 OD of log phase yeast cells in YPD or SD-N were collected by centrifugation and
precipitated with 10% ice-cold TCA (trichloroacetic acid) for at least 30 minutes. The samples
were pelleted by centrifugation and washed with ice-cold acetone. Pellets were air dried and
resuspended in SSB (0.05 M Tris-HCI pH-6.8, 0.2% SOS, 5% glycerol, 0.2%
�-mercaptoethanol, 2 x 10- 5 % bromophenol blue, in water). The Atg7 samples were run on a
10% SOS-PAGE gel and transferred to a PVDF membrane (Millipore). The power supply,
cables, glass plates, SOS-PAGE and transfer apparatus were from BioRad. The membrane was
cut at 63 kDa and probed with antibodies in 4% w/v nonfat dairy milk in TBST: I: 10,000
primary mouse anti-Pgkl from Abeam (cat. #22C5O8), 1:5,000 secondary
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peroxidase-conjugated goat anti-mouse (cat. #115-035-003), and a I: 10,000 rabbit
peroxidase-anti-peroxidase (cat. #323-005-024)) from Jackson ImmunoResearch Laboratories
Inc. The Atg14 samples were run on a 15% SOS-PAGE gel and transferred to a PVDF
membrane. The membrane was cut at 23 kDa and probed with the following antibodies in 4%
w/v nonfat dairy milk in TBST: l: 1,000 primary rabbit anti-histone H3 (ab 1791) antibody from
Abeam, 1:5,000 secondary peroxidase-conjugated goat anti-rabbit (cat. #115-035-003) antibody
from Millipore, and a I:2,500 rabbit peroxidase-anti-peroxidase (cat. #323-005-024)) antibody
from Jackson ImmunoResearch Laboratories, Inc. Luminata Crescendo Western HRP substrate
(Millipore) was ust:,,d for the detection and the blot was imaged on a BioRad Chemidoc XRS+
system. The resulting blots were quantified using lmageJ.

2.5 Pho8A60 Assay
The assay was performed as described20 with the exception that PMSF was omitted from the lysis
buffer to avoid interference with the protein quantification reagent. Protein quantification was
performed in a 96 well plate using a BCA assay kit (ThermoFisher) and the absorbances were
measured on a BioTek Synergy 2 plate reader. The lysis buffer consisted of the following: 0.02
M PIPES KOH pH 6.8, 0.05 M KC!, 0.1 M KOAc, 0.01 M MgSO4, 0.01 mM ZnSO4, 0.5%
TX-100, in water. The reaction buffer used consisted of the following: 0.25 M Tris-HCI pH 8.5,
0.01 M MgSO4, 0.01 mM ZnSO4, and 0.4% TX-100 in water with 0.625 rng/mL
para-nitrophenyl phosphate (pNPP).
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2.6 Transmission Electron Microscopy (TEM)
Approximately 30 OD oflog phase yeast cells were starved for 3 hours in SD-N media. The cells
were fixed with K.MnO4, dehydrated in acetone, embedded in Spurr's resin, sectioned and
imaged by TEM. A Leica UC6 ultramicrotome at the University of Michigan Microscope Image
and Analysis Laboratory (U of M MIL) was used to take 70 nm sections of the resin block. The
sections were placed onto a 300 mesh copper grid and imaged using a JEOL JSM 1400
Transmission Electron Microscope at the U of M MIL. 6,000x images of the grid square were
taken to measure vacuole size in a cell. 30,000x images were taken of vacuoles to measure the
size of autophagic bodies. The autophagic bodies and vacuoles were traced using aWacom
Intuos Draw Creative Pen Tablet and Adobe Photoshop CC201 7 and the traced bodies were
measured using ImageJ (v1.5 1 S, FIJI bundle) by Hayley Cawthon.

Table 1 : Plasmids Used in this Study
Plasmids

Name

Tag

Source

I

pRS416-FLO5p-A TG7-PA

PA

Bernard et al.• 2015

2

pRS416-GAL3p-ATG7-PA

PA

Bernard et al., 2015

3

pRS41 6-A TG7p-A TG7-PA

PA

Bernard et al., 2015

4

pRS416-SEFlp-ATG7-PA

PA

Bernard et al., 2015

5

pRS406-FLO5p-A TG7-PA

PA

Cawthon et al.• 201 8

6

pRS406-GAL3p-A TG7-PA

PA

Cawthon et al., 20 1 8

12
7

pRS406-A TG7p-A TG7-PA

PA

Cawthon et al., 2018

8

pRS406-SEF/p-ATG7-PA

PA

Cawthon et al., 201 8

9

pRS406-ATGI4p-A TG14-PA

PA

This study

10

pRS406-ATGIp-A TGI4-PA

PA

This study

11

pRS406-ATG8p-ATG 14-PA

PA

This study

12

pRS406-GAL3p-A TGI4-PA

PA

This study

13

pRS406-A TG23p-ATG/4-PA

PA

This study

Table 2. Primers Used in this Study.
Number

Name

Primer

Sequence

292

A TG7 -500

Forward

GAGGATGCTGAATTAAGACAAAG

293

A TG7 500 down

Reverse

CAACGCTTTAGATATGAATGCC

306

pRS416 to 406f

Forward

/5PhosffAAGAAACCATTATTATCATGACATTAACC

307

pRS416 to 406r

Reverse

/5Phos/CAGGTGGCACTTTTCGG

308

A TG/p

Forward

acggtatcgataagcttACCTGCCACAAGGTTATTTCTAC

309

ADH I terminal

Reverse

ccgggctgcaggaattcGGTGTGGTCAATAAGAGCGAC

311

pUG inner

Reverse

GATCTCTAGACCTAATAAC

312

A TG7 +500

Reverse

CACCTAACCAGTAATAAAACCTGTAC

313

pRS406
lincarization

Reverse

AAGCTTATCGATACCGTCGACC

315

pRS CEN6 up

Forward

CGGAAATGTTGAATACTCATACTCTTCCC

316

pRS CEN6 down

Reverse

CATCCGCTTACAGACAAGCTG
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324

A TG8p

Forward

ggtatcgataagcttCCTTAAAMCTCCATTGAAGACTTTG

328

A TG23p

Forward

ggtatcgataagcttAACCAGACCTGGCAAMC

355

GAL3p

Forward

tcgacggtatcgataagcttTTGATGTAAGCGGAGGTGTGG

384

A TG/4-PA tag

Forward

aacagtcacaggacctcatgaccgatggtacgtggtaggcCGGATCCCCG
GGTTAATTAA

385

A TG/4-PA tag

Reverse

atgcaactttatacacacggcaggaaaaaaagtgcgcactGAATTCGAGCT
CGTTTAAAC

386

A TG/4 deletion

Forward

aaagggaagtaaaagttaaaaactagaatcctagtatgacCGGATCCCCGG
GTTAATTAA

404

A TG14 promoter

Forward

acggtatcgataagcttGAGGAAAAACCAATTTGCCTATTACA
A AAC

405

A TG14 flanking

Forward

TCGAAGATGAAAAATGACACTAATTTTGCGCTAATT
A

406

A TG14 flanking

Reverse

ATTGAAACCTTGTICGACGGCTTTCTIATTTATGGCA
AAC

414

A TG23p

Reverse

aattgggcaatgcatATTTACTTCTICACTTTATTTTGTTACC
TTATAG

415

GAL3p

Reverse

aattgggcaatgcatACTATGTGTTGCCCTACCTTTTTACTTI
TA

416

A TG/p

Reverse

aattgggcaatgcatTTTCTIAATTTCTCGTCTGGTGTTGTAA
AAGAG

417

A TG8p

Reverse

aattgggcaatgcatGTCTCTAGTAATTATTTTATTATGATTT
TCTCAAC

418

A TG/4 +1

Forward

ATGCATIGCCCAATTTGCCACCATAGAGCG

Table 3. Strains Used in this Study.
Name

Genotype

Source

FRY143

SEY6210 vps4/J::TRPJ pep4/J::LEU2

Cheong et al. 2005

SEY62 10

MA Ta lzis3�200 /e112-3, 112 �vs2-80/ s11c2-tJ9
tlpltJ901 ura3-52

Robinson Klionsky
Emr 1988
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SKB421

FRYl43 atg7L1::HIS5

Cawthon ct al., 20 1 8

SKB447

WLYI 76 atg7L1::HIS5

Cawthon et al., 2018

SKB461

WLYI 76 alg7L1::HJS5
ura3-52::pRS406-A TG7p-ATG7-PA

Cawthon et al., 20 1 8

SKB462

WLY l76 atg7L1::H/S5
ura3-52::pRS406-GAL3p-ATG7-PA

Cawthon et al., 201 8

SKB464

WLYl76 atg7L1::HIS
ura3-52::pRS406-FLO5p-A TG7-PA

Cawthon ct al., 201 8

SKB467

WLYI 76 atg7L1::HIS
uraJ-52: :pRS406-SEFIp-ATG7-PA

Cawthon et al., 20 I 8

SKB478

WLYl76 atg7LJ::HIS5 11ra3-52::pRS406

Cawthon et al., 201 8

SKB494

FRY l43 atg7L1::HIS5
11ra3-52::pRS406-A TG7p-A TG7-PA

Cawthon et al., 20 1 8

SKB495

FRYl43 atg7L1::HIS5
ura3-52: :pRS406-GAL3p-A TG7-PA

Cawthon ct al., 2018

SKB496

FRY l43 atg7L1::HIS5
uraJ-52: :pRS406-FLO5p-ATG 7-PA

Cawthon et al., 2018

SKB497

FRY l43 atg7L1::HIS5 ura3-52::pRS406

Cawthon et al., 2018

SKB693

WLYI 76 atgl4A::KAN

This study

SKB738

WLY I 76 atg14A::H/S5 11ra3-52::
pRS406-ATG/p-A TG14-PA #3

This study

SKB739

WLY176 atg14L1::H/S5 ura3-52::
pRS406-A TG8p-ATG14-PA # I

This study

SKB740

WLYI 76 atgl4L1::HIS5 11ra3-52::
pRS406-A TG8p-A TG14-PA #2

This study

SKB741

WLYl76 atg/4A::HIS5 11ra3-52::
pRS406-A TG8p-A TG14-PA #3

This study

SKB742

WLY 176 atgl4L1::HJS5 ura3-52::
pRS406-ATG8p-A TG14-PA #4

This study
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SKB743

WLY176 atg/4LJ::HIS5 ura3-52::
pRS406-A TG8p-ATGJ4-PA #6

This study

SKB744

WLY 176 atgl 4LJ::HIS5 ura3-52::
pRS406-ATG23p-ATGJ4-PA #1

This study

SKB745

WLY 176 atgl4LJ::HIS5 ura3-52::
pRS406-A TG23p-A TGl4-PA #3

This study

SKB746

WLY176 atg/4LJ::HIS5 ura3-52::
pRS406-A TG23p-A TGl4-PA #4

This study

SKB747

WLY176 atg/4LJ::HIS5 ura3-52::
pRS406-Galp-A TGl4-PA #2

This study

WLY 176

SEY62 10 p/rol JLJ p/ro8L160

Kanki et al.. 2009

YAB292

YTS 158 atg7LJ::HIS5

Bernard et al.. 2015
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3.0 Results
3.1.1 A TG7 Deletion
To test whether Atg7 levels controlled the size and/or number of autophagosomes, we
first had to create mutant yeast which would yield a variety of Atg7 levels. ATG7 plasmids with
various promoters were provided by Dr. Klionsky. However, we first needed to create yeast
strains without the native copy of ATG7. Homologous recombination was used to delete ATG7
by using a PCR fragment of a histidine gene with homology to the ends of ATG7.

bp
1 0. 000

3000
2000
1500
1000

750
500

250

Figure 3. ATG7 deletion in FRY143 strain. PCR and agarose gel electrophoresis was used to verify the
deletion of ATG7 from FRY143. Lane 1: Marker. Lane 2: FRY143 wild type. Lane 3: FRY143
atg7L1::HIS5 clone 2. Lane 4: FRY143 atg7L1::HIS5 clone 2. Lane 5: atg7L1::HIS5. Lane 6: Marker. Lane
7: FRY143 wildtype. Lane 8: FRY143 atg7L1::HIS5 clone 2. Lane 9: FRY143 atg7t1::HIS5 clone 5. Lane

10: atg7LJ::HIS5. Primers 292/3 1 1 (detects H/S5) were used for lanes 2-5 and primers 292/3 12 (detects
ATG7) were used for lanes 7-10.
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This deletion of ATG7 from the FRY143 strain was verified by PCR and gel electrophoresis as
shown in Figure 3. Genomic yeast DNA from putative clones was used in a PCR with the
following sets of primers: 292/311 and 292/312. The first set of primers (292/311) detected the
presence of the histidine gene whereas the second set of primers(292/3 l 2) were used to verify
the removal of ATG7. The presence of the bands on the left (Lanes 3-5} shows the presence of
the histidine gene. The absence of bands on the right (Lanes 8-10} shows that ATG7 was
knocked out. The same methodology was used to verify ATG7 deletion inWLY l 76 (data not
shown).

3.1.2 Conversion of pRS416 to pRS406
The plasmid pRS41 6 contains a CEN6 sequence, which is the origin of replication in
yeast and allows multiple copies of plasmids to be present in the final strains. Multiple copies
would lead to inconsistent levels of ATG7 expression. Therefore, the CEN6 sequence was
removed from pRS416 plasmids containing ATG7 to create the corresponding pRS406 plasmids.
This was done by amplifying the plasmid, with the exception of the CEN6 sequence, by PCR.
The resulting linearized plasmids were then re-circularized by ligation and checked by PCR with
primers that flank the CEN6 sequence, as shown in Figure 4. The negative control
(pRS416-CUp-PA) is the linearized plasmid with the CEN6 sequence and is represented by the
band in Lane 2 at ~750 bp. Lane 3-12 contained circular plasmids without the CEN6 sequence,
which yielded bands at ~250 bp. The smaller band size verifies that the CEN6 was removed.
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Figure 4. Conversion ofpRS416 to pRS406. PCR products used t o verify that the CEN6 sequence was
removed from the pRS4 l 6 plasmid were separated on an agarose gel. Lane I : I kb Ladder. Lane 2:
pRS416-CUp-PA (negative control). Lane 3: ATG7p clone 1. Lane 4: A TG7p clone 2. Lane 5: GAL3p
clone l . Lane 6: GAL3p clone 2. Lane 7: FL05p clone I . Lane 8: FL05p clone 2. Lane 9: SEFJp clone l .
Lane 10: SEFlp clone 2.

3.1.3 Expression of Atg7 Using Mutant Strains
The pRS406 plasmids containing ATG7 under different promoters were integrated into
FRY143 atg7tJ::HIS5 yeast to create strains expressing different levels of A TG7. Cultures of
each strain were analyzed by western blot to verify the level of A TG7 expression (Figure 5).
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Figure 5. Western blot ofWLYl76 mutant strains expressing various levels of Atg7. A TG7p is the

native promoter, while atg7L1 is the negative control. Samples were processed at 0-hour starvation and 3
hours starvation in SD-N. Pgkl was used as a loading control.

Each lane contains a mutant strain with A TG7-PA expressed under a different promoter.
The PA is the Protein A tag and it allows for the visualization of Atg7 on a western blot. The size
and intensity of the bands indicate the amount of Atg7 protein expression. The quantification
shows that the Atg7 expression levels are approximately the same when comparing O hours and 3
hour starvation periods. It is also shown that there is an increase in Atg7 levels as the strength of
the promoter is increased.

3.1.4 Atg7 Levels Affect Autophagic Flux
Having demonstrated that different promoters caused a change in Atg7 levels, we then
performed a Pho8660 assay to show the effect of different Atg7 levels on autophagic activity.
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Figure 6. The autophagic activity of mutant ATG7 strains with different promoters. The mutant

strains were analyzed by Pho8�60 assay to measure total autophagic flux. The protein concentration was
also measured in order to determine the amount of autophagic flux per unit of protein. These were
normalized to the A TG7p (native promoter) at 3-hour starvation to give a percentage of autophagic
activity compared to wild type Atg7.

The mutant strains show approximately the same amount of autophagic activity under
nutrient-rich conditions (0-hour starvation). However, after 3 hours of nitrogen starvation, the
autophagic activity increased as the strength of the promoters increased. This shows that the
increasing Atg7 leads to an increase in autophagic flux and that autophagy is upregulated under
starvation conditions. Lastly, the effect of the ATG7p and SEFlp on Atg7 expression levels
seemed to be very similar and there was no significant difference in autophagic activity.
Therefore, SEFlp was omitted for the rest of the experiments.
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3.1.5 Atg7 Affect Size and Number of Autophagosomes
After determining that increasing Atg7 levels increases autophagic flux, we tested
whether this occurred due to a change in the size and/or the number of autophagosomes. Samples
were imaged using transmission electron microscopy as shown in Figure 7.

Figure 7. TEM images of Atg7 mutant strains. Images were taken after cells were starved for 3 hours

in SD-N. Each image is taken at 30,000x magnification. Scale bar-600 nm. Figure from Cawthon et al. .
ref 2 1 .
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Cells with no Atg7 (atg7L1) showed the least amount of autophagic bodies. As we increased the
strength of the promoters (Atg7 protein levels), we saw an increase in the numbers of
autophagosomes in the vacuoles. The images were analyzed to measure the average autophagic
body volume and the average number of autophagic bodies per cell from each strain as described
in the methodology. After analysis, it was found that Atg7 levels affected both the size and
number of autophagosomes as shown in Figures 8 and 9.
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Figure 8. Observed radii of autophagic bodies in Atg7 mutant strains. Split violin plot shows the
cross section radii of autophagic bodies from TEM analysis. The horizontal bars represent the mean
radius. Sample 1 and Sample 2 were imaged independently and their data were compared. Figure from
Cawthon et al., ref 21.
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Figure 9. Observed number ofcross-sections of autophagic bodies per vacuole. Split violin plot
shows the number of body cross-section in a cell detennined from TEM analysis. The horizontal bars
represent the mean number of body cross-sections per cell. Sample I and Sample 2 were imaged
independently and their data were compared. Figure from Cawthon et al.. ref2 J .

The data from the microscopy was also fitted to a mathematical model that estimated the average
size and number of autophagic bodies per mutant Atg7 strain, as shown in Figure 10.
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Figure 10. The estimated mean volume of autophagic bodies. All mutant strains were grown and

starved in SD-N for 3 hours. They were then prepped and imaged by TEM. (A)The images were analyzed
and the data were fitted to a mathematical model, which estimated the mean autophagic body volume. (B )
The image analysis data was also fitted to a mathematical model to estimate the mean number of
autophagic bodies per cell. Sample I and Sample 2 were imaged independently and their data were
compared. Figure from Cawthon et al., ref 21.

Both sets of samples showed similar results for each mutant strain. These mathematical model
also showed that both the volume and number of autophagic bodies increased as the amount of
Atg7 increased. This trend was consistent with the trend seen in the raw data. This concludes that
Atg7 affects the size and number of autophagosomes during nonselective autophagy. The same
methodology was then used to study Atgl4, a protein that is involved in autophagosome
formation.
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3.2.1 A TG14 Deletion
The first step to creating strains containing various levels of ATG I 4 was to delete the
native copy ATG14 from the WLY 176 strain}. Homologous recombination was used to delete

ATG/4 by using a PCR fragment ofa kanamycin gene with homology to both ends of ATGJ4.
This deletion was verified by PCR and gel electrophoresis as shown in Figure 9.
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Figure 12. Deletion of ATG14 in WLYl 76 strain. PCR using primers (404 and 406), which anneal on
either side of the ATGJ4 gene, was used to verify that ATGJ4 was knocked out of WLYI 76. Lane 1:
Ladder. Lane 2 and 3: WLY l 76 wild type. Lanes 4 and 5: putative WLYl 76 atgl4.d:: KAN clones.
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The presence of the bands around -4,000 bp signifies wild type WLYI 76 which contains
ATG14. The bands at ~1,500 bp represent WLYI 76 atg14LJ::ka11. The smaller size of the
WLY176 atgl 4LJ::KAN verifies that ATG 14 was removed and replaced with a kanamycin gene.

3.2.2 PA tagging ATG14
In a separate WLYI 76 strain, ATG14 was also tagged with Protein A (PA) tag using
primers 384 and 385. The tagging allows Atg14 to be recognized on a western blot. To make
sure the tagging did not affect the activity of Atgl 4 in non-selective autophagy, we performed a
Pho8�60 assay as shown in Figure 13.
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Figure 13. Pho8A60 assay to verify autophagic flux in the ATGU�PA strain. The autophagic activity
of wild type WLY l 76 was compared against the Atgl4-PA and atg/4tJ strains under normal and 3-hour
nitrogen starvation conditions. N "" 4. Error bars represent 95% confidence interval.
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The Pho8�60 assay compared the autophagic activity of wild type WLY176, ATG/4-PA,
and atg14L1 strains under nonnal (0-hour) and 3-hour nitrogen starvation conditions. Under
nonnal conditions, all three of the strains show approximately identical low levels of autophagic
activity. However, upon the 3-hour nitrogen starvation, only the wild type WLY I 76 and the
ATG14-PA strain had similar levels. This shows that the PA tag does not affect Atgl 4's ability in

selective autophagy. The atgl4J strain exhibited significantly lower levels of autophagic activity
than the other two strains, verifying the importance of Atg l 4 in autophagy.

3.2.3 Expression of Atg14 Under Different Promoters
After the PA-tagging of ATG14, promoters were picked based on published RNA
sequence data to create a variety of Atg14 protein levels. The chosen promoters (ATGJp, ATG8p,
ATG23p, and GAL3p) were amplified from genomic yeast DNA and inserted into plasmids
containing ATG14-PA which were used to create mutant Atg14 strains. Next, we perfonned a
western blot to test whether these promoters gave a variety of Atg14 expression, as shown in
Figure 14.
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Figure 14. Western blot to verify Atg14 levels. Western blot was perfonned to verify that strains with
various promoters gave distinct expression of ATG/4. Lane 1 : ATG/4p (positive control). Lane 2: ATG/p.
Lane 3: ATG8p clone l . Lane 4: ATG8p clone 2. Lane 5: ATG23p clone l . Lane 6: ATG23p clone 2. Lane
7: GAL3p. Lane 8: atgl4L1 (negative control).
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According to the western blot, each promoter shows distinct levels of Atg14 expression.
This level of Atg 14 expression was determined by the size and intensity of the band. The clones
showed that the non-native promoter was consistent in Atg14 expression. ATGlp showed the
greatest expression followed by ATG8p, ATG23p, ATG14p, and GAL3p.
Now that strains have been found that express different levels of Atgl4, more Pho8660
assays will be performed to test Atg14's effect on autophagic activity. Afterward, TEM image
analysis will be performed to see whether any change in activity is due to the change in
autophagosome size and/or number.
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4.0 Discussion
4.1 Atg7 Results
In this paper, we examined whether Atg7 affects nonselective autophagic activity in yeast and
whether this is due to regulating the size and/or number of autophagosomes. Atg7 was chosen
because it is essential for autophagy to occur and is involved in the Atg12 and Atg8 conjugation
pathways. Determining Atg7's function can help us understand the function of the Atg8 system.
We hypothesized that Atg7 regulates nonselective autophagy by controlling the size of
autophagosomes.
To test this hypothesis, different levels of Atg7 needed to be expressed. Atg7 plasmids
gifted from Dr. Dan Klionsky contained different promoters, which would vary ATG7
expression. The Atg7 plasmids were successfully converted from pRS4 I 6 to pRS406 plasmids to
minimize cell-to cell variation and integrated into the WLYI 76 and FRYI43 strains. The
expression levels of Atg7 were verified by western blot and gave a gradient of expression levels.
FLO5p showed the least Atg7 expression and required multiple blots with stronger antibody
dilutions to verify its presence. GAL3p showed a higher expression that FL05p and ATG7p
(native promoter) showed an even higher level of expression. SEFlp showed slightly higher
expression levels than ATG7p.
Afterward, multiple Pho8Ll60 assays were performed to measure the autophagic flux of
the mutant Atg7 strains at basal conditions and at 3 hours starvation. It was determined that as
Atg7 protein levels increased, this lead to an increase in autophagic flux. FLO5p had the least
protein and thus the least activity, GAL3p had more protein and more activity, etc. Since ATG7p
and SEF l p were shown to have very similar Atg7 expression and autophagic activity, SEFlp
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was omitted from further analysis. The question remained of whether Atg7 caused this increase
in flux by contributing to an increase in the size or number of autophagosomes. This was
determined by TEM image analysis.
The TEM images of the Atg7 mutant strains verified that the increase in Atg7 leads to an
increase in autophagic activity, due to an increase in both the size and number of
autophagosomes. The change in autophagosome size was expected since Atg8, which is
downstream of Atg7, has been shown to affect the size of autophagosomes. It was also
previously known that decreasing Atg7 leads to a decrease in Atg8 conjugation to PE. 13
However, it was surprising to see that Atg7 affected the number of autophagosomes. This could
possibly mean that the conjugation of Atg12 to Atg5 affects the number of autophagosomcs
formed. To determine if this were true, Atgl2 and Atg5 could be investigated using the same
methodology we used for Atg7.

4.2 Atg7 Medical Relevance
A paper by Komatsu et al. described that mammalian Atg7 was shown to be a homolog of
the yeast Atg723• This suggests that the results regarding Atg7 in yeast could directly translate to
autophagy in mammals. This is significant, as it suggests that Atg7 might regulate mammalian
autophagy by controlling the size and number of autophagosomes. Atg7 has been implicated in
various pathologies such as neurodegenerative diseases, cancer, infectious disease, and
cardiovascular diseases - this research implies that regulating the expression of Atg7 could be a
therapy for these diseases.
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Neurodegenerative diseases, such as Huntington's and Parkinson's, are incurable conditions that
result in progressive deterioration and death of nerve cells. This deterioration is caused by the
aggregation of misfolded proteins. Autophagy is one of the major intracellular mechanisms
which can degrade misfolded proteins and maintain proteostasis. A paper by Gao et al. showed
that lack of Atg7, which decreases autophagy, leads to an accumulation of p62. The
accumulation of p62 promotes the aggregation of proteins and therefore, leads to
neurodegenerative diseases.24 It has also been shown that the deletion of Atg7 in the brain leads
to a reduction of midbrain dopaminergic (mDA) neurons. This is crucial because Parkinson's
disease is caused by a gradual loss of mDA neurons during aging.� This suggests that an
increase in Atg7 can clear up the p62 accumulation and protein aggregates.

Atg7 has also been implicated in cancer development. The two main characteristics of cancer are
uncontrollable proliferation and suppression of apoptosis. Atg7 has been shown to have various
roles in different cancers. For example, it has been shown that the increase of Atg7 decreases the
resistance of human breast cancer cells to photodynamic therapy26 and promotes actions of
tetrandrine, a bisbenzylisoquinoline alkaloid which exhibits potent anti-tumor effects in human
hepatocellular carcinoma.27 This shows how Atg7 can act as a tumor suppressor. However, Atg7
has also been shown to be an oncogene. For example, the overexpression of ATG7 leads to the
inhibition of p27, causing 02-M transition and growth of human bladder cancer cells.2R It has
also been shown that Atg7 deficiency produces an autophagy-deficient phenotype, shown by the
accumulation of p62, enlarged ER, and a large cytoplasm. This deficiency leads to inhibition of
PTEN (phosphate and tensin homolog)-deficient prostate tumor growth through protein
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homeostasis.29 Overall. this shows how Atg7 can act as an oncogene or a tumor suppressor,
based on the type of cancer.

In recent years, the role of autophagy in immunity has become of great interest. A TG7, in
particular, has been shown to play various roles in different infectious diseases. For example, the
knockout of A TG7 has lead to a quicker spread of Pseudomonas aeruginosa infection in mice,
which can cause an accumulation of p62, increased inflammatory response, and increased
mortality.Jo This suggests that Atg7 is critical for controlling P. aeruginosa infection and may be
a negative regulator of the inflammatory response. It was also established that Atg7 deficiency
prevents the clearance of Mycobacterium tuberculosis by human immunity-related GTPase
family M protein. J i This is significant because M. tuberculosis is the causative agent of
tuberculosis and has shown resistance to current antibiotics. A potential therapeutic could
involve increasing Atg7 concentrations to upregulate autophagy and efficiently eliminate M.

tuberculosis. 32 Atg7 has also been implicated in human papillomavirus (HPV) and hepatitis C
virus (HCV) research. The knockdown of A TG7 has shown to significantly enhance the
infectivity of HPV in natural host cells (primary human keratinocytes).JJ However, it was also
shown that suppression of Atg7 expression suppresses the replication ofHCV RNAJ4 and results
in apoptosis of HCV-infected human hepatocytes.ls This suggests that an increase in Atg7 or
autophagy plays a positive role in facilitating HCV infection.

Together, this research shows how Atg7 plays different roles in various pathologies. In
neurodegenerative diseases, overexpression of Atg7 can be used to clear up p62 accumulation
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and protein aggregates through upregulation in autophagy. However, the role of Atg7 varies in
cancer and infectious diseases. Atg7 can either act as an oncogene or a tumor suppressor
depending on the type of cancer and the stage of progression. In tenns of infectious diseases,
Atg7 can either suppress infections or promote it, depending on the type of infectious disease.
Ultimately, this shows that Atg7-dependent therapeutics can be designed to treat diseases from
different pathologies. Our results show that Atg7 controls both autophagosome size and number,
unlike Atg8 or Atg9, which either controls autophagosome size or number, respectively.
Therefore, causing a deficiency of Atg7 might be useful as a therapeutic for certain cases.
Further studies will be required to determine whether Atg7's ability to control both
autophagosome size and number makes it an efficient target of therapy in various pathologies.

4.3 Atgl 4 Results
We also looked at determining the function of Atg l 4 using the same methodology as Atg7. First,
we successfully PA-tagged Atg l 4 and verified its expression by western blot. However, we ran
into an issue with the western blot: the size of the Atg l 4-PA was too close to that of the loading
control Pgk l , and this would prevent accurate quantification of Atg14 levels. The loading control
was important since it ensured that any changes we saw in protein levels was due to the
expression of the gene and not because of the volumes of sample loaded. To solve this issue, we
used a smaller loading control, histone H 3.
Next, we had to create the mutant Atg l 4 strains with various promoters, unlike the Atg7
plasmids, which were given to us as a gift. The following promoters were picked based on RNA
expression data: ATGlp, ATG8p, ATG23p, and GAL3p. A western blot was performed to verify
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the expression levels of Atg14 under different promoters. It initially appeared as if these
promoters did not function properly, because some promoters displayed two PA bands (data not
shown), rather than the one band expected. After performing plasmid sequence analysis, it was
found that these plasmids did not contain a promoter in front of ATG14. The presence of two PA
bands was odd since the absence of a promoter would usually lead to minimal expression, but
ultimately the same conclusion was made: we needed to try again at creating mutant strains. We
picked new plasmid clones, verified that they contained the appropriate promoter, and
transformed them into the WLY I 76 strain. A western blot was then performed on the new Atgl 4
strains. I t was found that ATGlp showed the highest Atgl4 expression, followed by ATG8p,
ATG23p, and ATG14p (native promoter). GAL3p did not show any Atgl4 expression as
indicated by the lack of a band. However, there may be Atg14 present and its presence is
difficult to see due to the strong bands nearby. Future analysis will involve performing western
blots where GAL3p-ATG14-PA samples are treated with stronger antibody concentrations to
detect Atgl4.
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5.0 Conclusions
It was hypothesized that essential autophagy proteins Atg7 and Atg l 4 play a role in
controlling autophagy, where Atg7 controls the size and Atg 1 4 controls the number of
autophagosomes. A gradient of Atg7 protein levels was created by using non-native promoters
and verified by western blot. The autophagic activity was measured by Pho8�60 assay and the
autophagosomes size and number were analyzed by transmission electron microscopy (TEM). It
was found that a decrease in Atg7 decreased non-selective autophagy and decreased both the size
and number of autophagosomes. Atg l 4 was also subjected to the same methodology. Various
levels of Atg l 4 were successfully expressed using non-native promoters. Next, the mutant Atg l 4
strains will be tested for autophagic activity to determine the effects of the amount of Atg1 4 on
non-selective autophagy.
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